HTR1A and drug-induced dyskinesia: Thus, giving 5HT1a and 5HT1b agonists has two therapeutic benefits: (1) the DA pulse in the striatum is lower and is therefore less likely to cause dyskinesias as discussed above; (2) the therapeutic time window becomes longer (Figure 8C).